These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 26991151)

  • 1. Predictors of prevalent statin use among older adults identified as statin initiators based on Medicare claims data.
    Young JC; Stürmer T; Lund JL; Funk MJ
    Pharmacoepidemiol Drug Saf; 2016 Jul; 25(7):836-43. PubMed ID: 26991151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Algorithms to Identify Statin Intolerance in Medicare Administrative Claim Data.
    Colantonio LD; Kent ST; Huang L; Chen L; Monda KL; Serban MC; Manthripragada A; Kilgore ML; Rosenson RS; Muntner P
    Cardiovasc Drugs Ther; 2016 Oct; 30(5):525-533. PubMed ID: 27389413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of statin adherence among beneficiaries in MA-PD plans versus PDPs.
    Jung K; McBean AM; Kim JA
    J Manag Care Pharm; 2012 Mar; 18(2):106-15. PubMed ID: 22380470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient adherence to generic versus brand statin therapy after acute myocardial infarction: Insights from the Can Rapid Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the American College of Cardiology/American Heart Association Guidelines Registry.
    O'Brien EC; McCoy LA; Thomas L; Peterson ED; Wang TY
    Am Heart J; 2015 Jul; 170(1):55-61. PubMed ID: 26093864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Region and Hospital and Patient Characteristics With Use of High-Intensity Statins After Myocardial Infarction Among Medicare Beneficiaries.
    Bittner V; Colantonio LD; Dai Y; Woodward M; Mefford MT; Rosenson RS; Muntner P; Monda KL; Kilgore ML; Jaeger BC; Levitan EB
    JAMA Cardiol; 2019 Sep; 4(9):865-872. PubMed ID: 31339519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute kidney injury in statin initiators.
    Layton JB; Brookhart MA; Jonsson Funk M; Simpson RJ; Pate V; Stürmer T; Kshirsagar AV
    Pharmacoepidemiol Drug Saf; 2013 Oct; 22(10):1061-70. PubMed ID: 23960024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of an intervention to increase statin use in medicare members who qualified for a medication therapy management program.
    Stockl KM; Tjioe D; Gong S; Stroup J; Harada AS; Lew HC
    J Manag Care Pharm; 2008; 14(6):532-40. PubMed ID: 18693777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin use following hospitalization among Medicare beneficiaries with a secondary discharge diagnosis of acute myocardial infarction.
    Yun H; Safford MM; Brown TM; Farkouh ME; Kent S; Sharma P; Kilgore M; Bittner V; Rosenson RS; Delzell E; Muntner P; Levitan EB
    J Am Heart Assoc; 2015 Feb; 4(2):. PubMed ID: 25666367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of manufacturer coupon use in the statin market.
    Daugherty JB; Maciejewski ML; Farley JF
    J Manag Care Pharm; 2013; 19(9):765-72. PubMed ID: 24156645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Medicare Part D medication out-of-pocket costs with utilization of statin medications.
    Karaca-Mandic P; Swenson T; Abraham JM; Kane RL
    Health Serv Res; 2013 Aug; 48(4):1311-33. PubMed ID: 23278369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding gender differences in statin use among elderly Medicare beneficiaries: an application of decomposition technique.
    Bhattacharjee S; Findley PA; Sambamoorthi U
    Drugs Aging; 2012 Dec; 29(12):971-80. PubMed ID: 23160960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effectiveness of generic and brand-name statins on patient outcomes: a cohort study.
    Gagne JJ; Choudhry NK; Kesselheim AS; Polinski JM; Hutchins D; Matlin OS; Brennan TA; Avorn J; Shrank WH
    Ann Intern Med; 2014 Sep; 161(6):400-7. PubMed ID: 25222387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restriction of Pharmacoepidemiologic Cohorts to Initiators of Medications in Unrelated Preventive Drug Classes to Reduce Confounding by Frailty in Older Adults.
    Zhang HT; McGrath LJ; Ellis AR; Wyss R; Lund JL; Stürmer T
    Am J Epidemiol; 2019 Jul; 188(7):1371-1382. PubMed ID: 30927359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin Discontinuation, Reinitiation, and Persistence Patterns Among Medicare Beneficiaries After Myocardial Infarction: A Cohort Study.
    Booth JN; Colantonio LD; Chen L; Rosenson RS; Monda KL; Safford MM; Kilgore ML; Brown TM; Taylor B; Dent R; Muntner P; Levitan EB
    Circ Cardiovasc Qual Outcomes; 2017 Oct; 10(10):. PubMed ID: 29021332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classifying medical histories in US Medicare beneficiaries using fixed vs all-available look-back approaches.
    Conover MM; Stürmer T; Poole C; Glynn RJ; Simpson RJ; Pate V; Jonsson Funk M
    Pharmacoepidemiol Drug Saf; 2018 Jul; 27(7):771-780. PubMed ID: 29655187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge.
    Lee HY; Cooke CE; Robertson TA
    J Manag Care Pharm; 2008 Apr; 14(3):271-80. PubMed ID: 18439049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Industry Payments to Physicians With the Prescribing of Brand-name Statins in Massachusetts.
    Yeh JS; Franklin JM; Avorn J; Landon J; Kesselheim AS
    JAMA Intern Med; 2016 Jun; 176(6):763-8. PubMed ID: 27159336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pattern of statin use among 10 cohorts of new users from 1995 to 2004: a register-based nationwide study.
    Helin-Salmivaara A; Lavikainen PT; Korhonen MJ; Halava H; Martikainen JE; Saastamoinen LK; Virta L; Klaukka T; Huupponen R
    Am J Manag Care; 2010 Feb; 16(2):116-22. PubMed ID: 20148616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with statin selection among privately insured commercial and Medicare patients.
    Zhao Z; Bae J; Sponseller CA; Zhu Y; Kryzhanovski VA; LeNarz LA
    Curr Med Res Opin; 2013 Apr; 29(4):395-404. PubMed ID: 23406054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agreement between Medicare pharmacy claims, self-report, and medication inventory for assessing lipid-lowering medication use.
    Colantonio LD; Kent ST; Kilgore ML; Delzell E; Curtis JR; Howard G; Safford MM; Muntner P
    Pharmacoepidemiol Drug Saf; 2016 Jul; 25(7):827-35. PubMed ID: 26823152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.